Evopoint (Beijing) Clinical Trial Registry officially launched on July 23, 2021

On July 23, 2021, Evopoint (Beijing) moved to a new office, marking that Evopoint's strategic layout has been fully completed and officially launched, with Suzhou as its Global Headquarters, R&D Center and Production Base, Shanghai as its Clinical Research Center, and Beijing as its Clinical Trial Registry.